Participation in Australian drug treatment programs for individuals engaging in high‐risk substance use: Data from a nationally representative sample.

Autor: Leung, Janni, Yimer, Tesfa Mekonen, Chiu, Vivian, Hall, Wayne D., Connor, Jason P., Chan, Gary Chung Kai
Předmět:
Zdroj: Drug & Alcohol Review; Mar2024, Vol. 43 Issue 3, p688-693, 6p
Abstrakt: Introduction: Substance use, including drugs, alcohol and smoking have a significant health, social and economic impact. We aim to assess the rate and factors associated with treatment access among individuals with high‐risk substance use. Method: This study is a cross‐sectional analysis of the 2019 Australian National Drug Strategy Household Survey (N = 22,015). Participants were persons with high‐risk substance use based on the Alcohol, Smoking and Substance Involvement Screening Test—Lite (ASSIST‐Lite) and current smokers. We measured self‐reports of past 12‐month engagement in a tobacco, alcohol or other drugs treatment program. Results: Overall, 0.4% had high‐risk drug use (0.3% cannabis, 0.1% meth/amphetamine or 0.1% opioids), 7.4% had high‐risk alcohol use, and 14.0% currently smoked. Among high‐risk users, past 12‐month treatment access rates were 50.6% [22.3–78.9%] for opioids, 27.1% [8.1–46.1%] for meth/amphetamine, 14.5% [4.3–24.7%] for cannabis, 9.6% [8.1–11.0%] for alcohol and 11.7% [10.6–12.9%] for current smoking. The primary source of treatment support was information and education (12.7% drugs, 4.6% alcohol, 4.0% smoking), followed by counselling (6.7% drugs, 4.5% alcohol, 3.0% smoking). Online or internet support was accessed by 5.9% (drug) and 1.6% (alcohol) people with high‐risk use. Psychological distress was associated with treatment access (drugs: odds ratio 3.03 [0.77–11.95], p = 0.111; alcohol: odds ratio 3.16 [2.20–4.56], p ≤ 0.001; smoking: odds ratio 1.95 [1.52–2.49], p ≤ 0.001). Discussion and Conclusions: The proportion of people engaging in risky substance use who had used treatment programs remains low, especially for alcohol. Public health strategies to scale up treatment access are warranted. [ABSTRACT FROM AUTHOR]
Databáze: Complementary Index